Header Logo

Connection

PATRICIA BAXTER to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications PATRICIA BAXTER has written about Drug Evaluation, Preclinical.
PATRICIA BAXTER
Connection Strength
0.047
Drug Evaluation, Preclinical
  1. Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies. Lab Invest. 2022 02; 102(2):185-193.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.